Randomized, placebo-controlled Phase 2a study of SPL026 met its primary endpoint demonstrating a clinically significant reduction in depressive ...

A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive ...

"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...

Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.

A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other ...

Greater consumption of sugar-sweetened beverages was associated with a 34% increased risk for anxiety disorders, a ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

The idea that depression is caused by a chemical imbalance in the brain is more than half a century old. The reality is more ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major depressive disorder after analyzing a short WhatsApp audio recording where ...

Please provide your email address to receive an email when new articles are posted on . Genetic major depressive disorder was linked to genetic liability for PAD. The association between genetic ...